Merger date of India’s P&C giants in doubt
February 5 2019 by Andrew Tjaardstra
-
P&C GWP growth in mature APAC markets to reach 3.2% in 2024: Swiss Re
- November 20
Emerging Asia will remain the main driving force with non-life premiums to grow at a 7.4% CAGR in 2025‒26 as India outperforms all major developing markets.
-
Market’s willingness to deploy capacity is certainly back: Gallagher Re
- November 1
Gallagher Re’s Mark O’Brien says negotiations around retentions, and terms and conditions to be a little easier in the coming renewals.
-
Pacific rates drop 6% in Q3 driven by declines in finpro, cyber and property lines: Marsh
- October 25
Finpro premiums was down 14%, while cyber cover saw a 11% disclose and property declined 6% as increased competition and capacity weighed on ratings.
-
Asia insurance rates drop 4% in Q3 led by finpro and cyber lines: Marsh
- October 24
Finpro lines have seen decreases up to 30% in some cases as continued lack of activity in the capital markets limited insurers' opportunities for new business, according to the latest Global Insurance Market Index by the broker.
-
BHSI | Managing non-Asian exposure in long-tail lines
While US-exposed business can look attractive to Asian carriers, managing the volatility around the long-term results and the ability to model those losses are crucial, say BHSI’s Marc Breuil and Marcus Portbury.
-
Sedgwick | To Handle CAT Claims Well, Multi-Step Preparation is Key
When it comes to risk, it’s not a matter of “if” it’s a matter of “when” an event will occur.
-
HSBC Asset Management | Is it time to relook at Asian currency bonds?
With diversification and performance high on investors’ agendas, it seems a good time for global portfolios to revive allocations in Asian local currency bonds – including Hong Kong dollar (HKD) bonds.
-
PineBridge Investments | Why Asian insurers are exploring private credit and CLOs
The recent rollout of risk-based capital regimes across Asia calls for a closer alignment between insurers’ assets and liabilities. We explore potential ways to maintain a healthy investment yield and robust returns on regulatory capital.
